Northwest Biotherapeutics, Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $-73.1M | $-80.2M | $-114.7M | $-135.6M | $-65.8M | $-67.3M | $-32.8M | $-27.4M |
| Depreciation & Amortization | $439.0K | $189.0K | $56.0K | $11.0K | $11.0K | $14.0K | $10.0K | $2.0K |
| Depreciation | $400.0K | $189.0K | $56.0K | $12.0K | — | — | — | — |
| Amortization | — | — | — | — | — | — | — | — |
| Stock-Based Compensation | $842.0K | $127.0K | $3.4M | $0 | $1.4M | $3.2M | $8.4M | $2.0M |
| Net Cash from Operating Activities | $-36.5M | $-55.7M | $-78.6M | $-54.6M | $-37.8M | $-22.8M | $-14.7M | $-6.4M |
| Investing Activities | ||||||||
| Capital Expenditures | — | — | — | — | $-1.0K | $31.0K | $49.0K | $41.0K |
| Business Acquisitions | — | — | — | — | — | — | — | — |
| Net Cash from Investing Activities | $212.0K | $-4.9M | $-6.8M | $-36.4M | $1.0K | $-31.0K | $-49.0K | $-41.0K |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | — | — | $0 | $0 | $240.0K | — | — | — |
| Net Cash from Financing Activities | $34.3M | $38.3M | $94.2M | $85.8M | $49.0M | $30.1M | $14.6M | $6.6M |
| Net Change in Cash | $-6.8M | $-16.2M | $8.4M | $-5.1M | $11.2M | $7.3M | $-129.0K | $88.0K |
| Free Cash Flow | — | — | — | — | $-37.8M | $-22.8M | $-14.8M | $-6.4M |